2020 Q1 Form 10-Q Financial Statement

#000143774920010283 Filed on May 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $165.8M $141.4M
YoY Change 17.27% 9.46%
Cost Of Revenue $74.33M $63.36M
YoY Change 17.32% 9.89%
Gross Profit $91.45M $78.01M
YoY Change 17.23% 9.11%
Gross Profit Margin 55.16% 55.18%
Selling, General & Admin $32.16M $30.55M
YoY Change 5.27% 11.84%
% of Gross Profit 35.17% 39.17%
Research & Development $25.96M $25.46M
YoY Change 1.96% 17.81%
% of Gross Profit 28.38% 32.64%
Depreciation & Amortization $4.328M $3.255M
YoY Change 32.96% 18.15%
% of Gross Profit 4.73% 4.17%
Operating Expenses $60.46M $56.29M
YoY Change 7.41% 13.81%
Operating Profit $30.99M $21.72M
YoY Change 42.68% -1.45%
Interest Expense $2.374M $1.696M
YoY Change 39.98% 16.16%
% of Operating Profit 7.66% 7.81%
Other Income/Expense, Net -$1.714M $3.341M
YoY Change -151.3% 659.32%
Pretax Income $29.27M $25.06M
YoY Change 16.82% 11.48%
Income Tax -$6.500M -$1.100M
% Of Pretax Income -22.21% -4.39%
Net Earnings $35.76M $26.18M
YoY Change 36.57% 19.79%
Net Earnings / Revenue 21.57% 18.52%
Basic Earnings Per Share $0.80 $0.61
Diluted Earnings Per Share $0.77 $0.58
COMMON SHARES
Basic Shares Outstanding 44.46M 42.75M
Diluted Shares Outstanding 46.67M 45.23M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $489.3M $359.0M
YoY Change 36.3% 16.82%
Cash & Equivalents $154.9M $181.8M
Short-Term Investments $334.4M $177.3M
Other Short-Term Assets $29.68M $13.63M
YoY Change 117.76% -18.42%
Inventory $131.5M $142.5M
Prepaid Expenses $18.44M $3.298M
Receivables $54.30M $58.89M
Other Receivables $8.300M $6.300M
Total Short-Term Assets $704.8M $574.1M
YoY Change 22.77% 18.59%
LONG-TERM ASSETS
Property, Plant & Equipment $236.8M $205.5M
YoY Change 15.24% 33.64%
Goodwill $6.571M $6.571M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $3.100M $3.300M
YoY Change -6.06% -37.74%
Other Assets $42.46M $41.99M
YoY Change 1.13% 33.16%
Total Long-Term Assets $302.7M $274.1M
YoY Change 10.43% 28.3%
TOTAL ASSETS
Total Short-Term Assets $704.8M $574.1M
Total Long-Term Assets $302.7M $274.1M
Total Assets $1.008B $848.2M
YoY Change 18.78% 21.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.75M $27.26M
YoY Change 38.49% -0.92%
Accrued Expenses $56.11M $45.35M
YoY Change 23.73% 38.55%
Deferred Revenue $5.221M $2.927M
YoY Change 78.37%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $112.5M $91.58M
YoY Change 22.84% 24.93%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $44.22M $42.01M
YoY Change 5.28% 22.61%
Total Long-Term Liabilities $44.22M $42.01M
YoY Change 5.28% 22.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $112.5M $91.58M
Total Long-Term Liabilities $44.22M $42.01M
Total Liabilities $194.3M $168.0M
YoY Change 15.69% 20.43%
SHAREHOLDERS EQUITY
Retained Earnings $241.5M $202.4M
YoY Change 19.31% 32.92%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $813.2M $680.3M
YoY Change
Total Liabilities & Shareholders Equity $1.008B $848.2M
YoY Change 18.78% 21.56%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $35.76M $26.18M
YoY Change 36.57% 19.79%
Depreciation, Depletion And Amortization $4.328M $3.255M
YoY Change 32.96% 18.15%
Cash From Operating Activities $51.42M $38.84M
YoY Change 32.4% 138.37%
INVESTING ACTIVITIES
Capital Expenditures $9.951M $58.38M
YoY Change -82.95% 688.86%
Acquisitions
YoY Change
Other Investing Activities -$54.50M $28.60M
YoY Change -290.56% -260.67%
Cash From Investing Activities -$64.46M -$30.78M
YoY Change 109.41% 22.14%
FINANCING ACTIVITIES
Cash Dividend Paid $17.43M $12.76M
YoY Change 36.56%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$4.056M -$761.0K
YoY Change 432.98% -173.67%
NET CHANGE
Cash From Operating Activities $51.42M $38.84M
Cash From Investing Activities -$64.46M -$30.78M
Cash From Financing Activities -$4.056M -$761.0K
Net Change In Cash -$18.08M $7.294M
YoY Change -347.87% -208.22%
FREE CASH FLOW
Cash From Operating Activities $51.42M $38.84M
Capital Expenditures $9.951M $58.38M
Free Cash Flow $41.47M -$19.54M
YoY Change -312.22% -319.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
172960000 USD
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
334386000 USD
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
282437000 USD
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44740000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44715000
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44715000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43616000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43616000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
55000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-98000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 pure
CY2020Q1 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2019 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154880000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
54341000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
52704000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
131499000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
127500000 USD
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
29679000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
19605000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
704785000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
655206000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
56110000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44790000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
112495000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
98225000 USD
CY2020Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
37596000 USD
CY2019Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
37596000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
44223000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30553000 USD
CY2020Q1 mpwr Litigation Expense Benefit Net
LitigationExpenseBenefitNet
2341000 USD
CY2019Q1 mpwr Litigation Expense Benefit Net
LitigationExpenseBenefitNet
278000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
60461000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
236807000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
228315000 USD
CY2020Q1 us-gaap Auction Rate Securities Noncurrent
AuctionRateSecuritiesNoncurrent
3057000 USD
CY2019Q4 us-gaap Auction Rate Securities Noncurrent
AuctionRateSecuritiesNoncurrent
3138000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
6571000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
6571000 USD
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13821000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
17193000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42463000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45952000 USD
CY2020Q1 us-gaap Assets
Assets
1007504000 USD
CY2019Q4 us-gaap Assets
Assets
956375000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
37752000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
27271000 USD
CY2020Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18633000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
26164000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
47063000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
194314000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
182884000 USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
581736000 USD
CY2019Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
549517000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
241465000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
229450000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10011000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5476000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
813190000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
773491000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1007504000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
956375000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
165778000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141363000 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
74331000 USD
CY2019Q1 us-gaap Cost Of Revenue
CostOfRevenue
63357000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
91447000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
78006000 USD
CY2020Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
25956000 USD
CY2019Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
25458000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32164000 USD
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
56289000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
30986000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
21717000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1714000 USD
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3341000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29272000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25058000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6484000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1123000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
35756000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
26181000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44455000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42749000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46670000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45232000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
35756000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
26181000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2882000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3677000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1653000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
826000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4535000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4503000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
31221000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
30684000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
773491000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
35756000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4535000 USD
CY2020Q1 us-gaap Dividends
Dividends
23741000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
11758000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1892000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18569000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
813190000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
640093000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
26181000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4503000 USD
CY2019Q1 us-gaap Dividends
Dividends
18531000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
10383000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1627000 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15995000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
680251000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
35756000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
26181000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4328000 USD
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3255000 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1000 USD
CY2019Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-14000 USD
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-494000 USD
CY2019Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-121000 USD
CY2020Q1 mpwr Gain Loss On Deferred Compensation Plan Investments Cash Flow
GainLossOnDeferredCompensationPlanInvestmentsCashFlow
-3750000 USD
CY2019Q1 mpwr Gain Loss On Deferred Compensation Plan Investments Cash Flow
GainLossOnDeferredCompensationPlanInvestmentsCashFlow
1935000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3412000 USD
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-33000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
18562000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
16010000 USD
CY2020Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1635000 USD
CY2019Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3676000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3994000 USD
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6171000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
10061000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1576000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7185000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4778000 USD
CY2020Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-7374000 USD
CY2019Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
34000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1491000 USD
CY2020Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
963000 USD
CY2019Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
3355000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
51419000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38836000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9952000 USD
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58376000 USD
CY2020Q1 mpwr Payments To Acquire In Place Leases
PaymentsToAcquireInPlaceLeases
-0 USD
CY2019Q1 mpwr Payments To Acquire In Place Leases
PaymentsToAcquireInPlaceLeases
981000 USD
CY2020Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
101566000 USD
CY2019Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
-0 USD
CY2020Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
47397000 USD
CY2019Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
28076000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
100000 USD
CY2019Q1 us-gaap Proceeds From Sale Of Longterm Investments
ProceedsFromSaleOfLongtermInvestments
0 USD
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000 USD
CY2019Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1456000 USD
CY2020Q1 mpwr Contributions Made To Deferred Compensation Plan
ContributionsMadeToDeferredCompensationPlan
438000 USD
CY2019Q1 mpwr Contributions Made To Deferred Compensation Plan
ContributionsMadeToDeferredCompensationPlan
956000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-64458000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30781000 USD
CY2020Q1 mpwr Property And Equipment Purchased On Extended Payment Terms
PropertyAndEquipmentPurchasedOnExtendedPaymentTerms
279000 USD
CY2019Q1 mpwr Property And Equipment Purchased On Extended Payment Terms
PropertyAndEquipmentPurchasedOnExtendedPaymentTerms
10000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
11758000 USD
CY2019Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
10383000 USD
CY2020Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1892000 USD
CY2019Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1627000 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
17427000 USD
CY2019Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
12761000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4056000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-761000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-985000 USD
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1770000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-18080000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
9064000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173076000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
172818000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
154996000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18562000 USD
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16010000 USD
CY2020Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
470000 USD
CY2019Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
838000 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
4053000
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
59.16
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
371000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
170.56
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1084000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
181882000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
279000 USD
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
393000 USD
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
10909000 USD
CY2019Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
958000 USD
CY2020Q1 mpwr Dividends And Dividend Equivalents Accrued
DividendsAndDividendEquivalentsAccrued
23725000 USD
CY2019Q1 mpwr Dividends And Dividend Equivalents Accrued
DividendsAndDividendEquivalentsAccrued
18534000 USD
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><i><b>Use of Estimates</b></i></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions used in these condensed consolidated financial statements primarily include those related to revenue recognition, inventory valuation, valuation of share-based awards, contingencies and income tax valuation allowances. </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><i><b> </b></i></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The coronavirus pandemic <em style="font: inherit;">first</em> identified in <em style="font: inherit;"> December 2019 (</em>“COVID-<em style="font: inherit;">19”</em>) has resulted in a global slowdown of economic activity which is likely to decrease demand for a broad variety of goods and services, while also disrupting sales channels, supply chains and other business operations for an unknown period of time until the disease is contained. These events could have a negative impact on the Company’s sales and results of operations for the remainder of <em style="font: inherit;">2020,</em> but the Company is currently unable to predict the size and duration of such impact. As of the date of issuance of these condensed consolidated financial statements, the Company is <em style="font: inherit;">not</em> aware of any specific event or circumstance that would require management to update the significant estimates and assumptions used in the preparation of the condensed consolidated financial statements, as compared to those disclosed in the Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2019. </em>As new events continue to evolve and additional information becomes available, these estimates and assumptions <em style="font: inherit;"> may </em>change and will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and assumptions, and any such differences <em style="font: inherit;"> may </em>be material to the Company’s financial statements. </p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </p>
CY2020Q1 mpwr Lapse Period For Consignment
LapsePeriodForConsignment
P60D
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
54300000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
52700000 USD
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3200000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
54.85
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
12000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
83.20
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3328000
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
72.88
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
61947000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
131499000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
127500000 USD
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
32502000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
22872000 USD
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
48022000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
42681000 USD
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
50975000 USD
CY2020Q1 mpwr Tax Withholding Share Based Payment Arrangement Proceeds Receivable
TaxWithholdingShareBasedPaymentArrangementProceedsReceivable
5744000 USD
CY2019Q4 mpwr Tax Withholding Share Based Payment Arrangement Proceeds Receivable
TaxWithholdingShareBasedPaymentArrangementProceedsReceivable
6106000 USD
CY2020Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18444000 USD
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7991000 USD
CY2020Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
2530000 USD
CY2019Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
2490000 USD
CY2020Q1 mpwr Product Return Assets Current
ProductReturnAssetsCurrent
1824000 USD
CY2019Q4 mpwr Product Return Assets Current
ProductReturnAssetsCurrent
1585000 USD
CY2020Q1 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1137000 USD
CY2019Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
1433000 USD
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
29679000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
19605000 USD
CY2020Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
35547000 USD
CY2019Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
38858000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2744000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2863000 USD
CY2020Q1 us-gaap Prepaid Expense Other Noncurrent
PrepaidExpenseOtherNoncurrent
2715000 USD
CY2019Q4 us-gaap Prepaid Expense Other Noncurrent
PrepaidExpenseOtherNoncurrent
2687000 USD
CY2020Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1457000 USD
CY2019Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
1544000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42463000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
45952000 USD
CY2020Q1 mpwr Dividends And Dividend Equivalents
DividendsAndDividendEquivalents
27846000 USD
CY2019Q4 mpwr Dividends And Dividend Equivalents
DividendsAndDividendEquivalents
21747000 USD
CY2020Q1 mpwr Stock Rotation Reserve And Accrued Sales Returns
StockRotationReserveAndAccruedSalesReturns
6474000 USD
CY2019Q4 mpwr Stock Rotation Reserve And Accrued Sales Returns
StockRotationReserveAndAccruedSalesReturns
5530000 USD
CY2020Q1 mpwr Accrued Purchases Of Property And Equipment Current
AccruedPurchasesOfPropertyAndEquipmentCurrent
5834000 USD
CY2019Q4 mpwr Accrued Purchases Of Property And Equipment Current
AccruedPurchasesOfPropertyAndEquipmentCurrent
4678000 USD
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2462000 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2435000 USD
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5221000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3412000 USD
CY2020Q1 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
2191000 USD
CY2019Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1425000 USD
CY2020Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1144000 USD
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1139000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3798000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3170000 USD
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
56110000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44790000 USD
CY2020Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
36627000 USD
CY2019Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
39665000 USD
CY2020Q1 mpwr Dividend Equivalents Noncurrent
DividendEquivalentsNoncurrent
6481000 USD
CY2019Q4 mpwr Dividend Equivalents Noncurrent
DividendEquivalentsNoncurrent
6265000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
29000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
30000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
44223000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
47063000 USD
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
366000 USD
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
305000 USD
CY2020Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
77000 USD
CY2019Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
98000 USD
CY2020Q1 us-gaap Lease Cost
LeaseCost
443000 USD
CY2019Q1 us-gaap Lease Cost
LeaseCost
403000 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
373000 USD
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
304000 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
277000 USD
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2264000 USD
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M6D
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.036 pure
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.037 pure
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2200000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
994000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
774000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
453000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
96000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
12000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2329000 USD
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
103000 USD
CY2020Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
400000 USD
CY2019Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
200000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
1620000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
2285000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
2074000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
1240000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
552000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
59000 USD
CY2020Q1 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
7830000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
35756000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
26181000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44455000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42749000
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2215000
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2483000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46670000
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45232000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.77
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.58
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
165778000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141363000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
165778000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141363000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154880000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
172960000 USD
CY2020Q1 us-gaap Short Term Investments
ShortTermInvestments
334386000 USD
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
282437000 USD
CY2020Q1 us-gaap Long Term Investments
LongTermInvestments
3057000 USD
CY2019Q4 us-gaap Long Term Investments
LongTermInvestments
3138000 USD
CY2020Q1 mpwr Cash Cash Equivalents And Investments
CashCashEquivalentsAndInvestments
492323000 USD
CY2019Q4 mpwr Cash Cash Equivalents And Investments
CashCashEquivalentsAndInvestments
458535000 USD
CY2020Q1 us-gaap Noncurrent Assets
NoncurrentAssets
236807000 USD
CY2019Q4 us-gaap Noncurrent Assets
NoncurrentAssets
228315000 USD
CY2019Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1139000 USD
CY2018Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
4564000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
541000 USD
CY2019Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
268000 USD
CY2020Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
111000 USD
CY2019Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
2271000 USD
CY2020Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
425000 USD
CY2019Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
516000 USD
CY2020Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
1144000 USD
CY2019Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2045000 USD
CY2020Q1 us-gaap Purchase Obligation
PurchaseObligation
102600000 USD
CY2020Q1 us-gaap Cash
Cash
143926000 USD
CY2019Q4 us-gaap Cash
Cash
144860000 USD
CY2020Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
10954000 USD
CY2019Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
28100000 USD
CY2020Q1 us-gaap Commercial Paper At Carrying Value
CommercialPaperAtCarryingValue
4943000 USD
CY2019Q4 us-gaap Commercial Paper At Carrying Value
CommercialPaperAtCarryingValue
1994000 USD
CY2020Q1 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
20534000 USD
CY2019Q4 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
19493000 USD
CY2020Q1 mpwr Cash Cash Equivalents And Investments
CashCashEquivalentsAndInvestments
492323000 USD
CY2019Q4 mpwr Cash Cash Equivalents And Investments
CashCashEquivalentsAndInvestments
458535000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
197000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
97393000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
261000 USD
CY2019 mpwr Auction Rate Securities Maturities
AuctionRateSecuritiesMaturities
P26Y
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
175874000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
175281000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
159928000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
159105000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
3220000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
3057000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
339022000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
337443000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
349976000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
603000 USD
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2182000 USD
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
348397000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
313546000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
390000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
261000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
313675000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
217538000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2019000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
3057000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
163000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
220595000 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
2182000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
83119000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
64000 USD
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
14274000 USD
CY2020Q1 mpwr Redemption Auction Rate Securities To Date
RedemptionAuctionRateSecuritiesToDate
40100000 USD
CY2020Q1 mpwr Percentage Of Auction Rate Securities Redeemedat Par Value
PercentageOfAuctionRateSecuritiesRedeemedatParValue
0.93 pure
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154880000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
172960000 USD
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
116000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
116000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
154996000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173076000 USD
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
2374000 USD
CY2019Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1696000 USD
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-494000 USD
CY2019Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-121000 USD
CY2020Q1 mpwr Gain Loss On Deferred Compensation Plan Investments
GainLossOnDeferredCompensationPlanInvestments
-3750000 USD
CY2019Q1 mpwr Gain Loss On Deferred Compensation Plan Investments
GainLossOnDeferredCompensationPlanInvestments
1935000 USD
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3000 USD
CY2019Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-201000 USD
CY2020Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
368623000 USD
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
335650000 USD
CY2020Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
35547000 USD
CY2019Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
38858000 USD
CY2020Q1 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
36782000 USD
CY2019Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
40090000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
153000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
32000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1714000 USD
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3341000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6500000 USD
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.222 pure
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1100000 USD
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.045 pure
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
22317000 USD
CY2019Q1 us-gaap Dividends Common Stock
DividendsCommonStock
17180000 USD
CY2020Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
22300000 USD
CY2019Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
17400000 USD
CY2020Q1 mpwr Accrued Dividend Equivalents
AccruedDividendEquivalents
12000000.0 USD
CY2019Q4 mpwr Accrued Dividend Equivalents
AccruedDividendEquivalents
10600000 USD

Files In Submission

Name View Source Status
0001437749-20-010283-index-headers.html Edgar Link pending
0001437749-20-010283-index.html Edgar Link pending
0001437749-20-010283.txt Edgar Link pending
0001437749-20-010283-xbrl.zip Edgar Link pending
ex_182985.htm Edgar Link pending
ex_182986.htm Edgar Link pending
ex_182987.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mpwr-20200331.xsd Edgar Link pending
mpwr-20200331_cal.xml Edgar Link unprocessable
mpwr-20200331_def.xml Edgar Link unprocessable
mpwr-20200331_lab.xml Edgar Link unprocessable
mpwr-20200331_pre.xml Edgar Link unprocessable
mpwr20200331_10q.htm Edgar Link pending
mpwr20200331_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending